COMMUNIQUÉS West-GlobeNewswire

Colin McCracken Joins Fluidigm as Chief Commercial Officer
05/03/2019
SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Colin McCracken has joined the company as its Chief Commercial Officer. McCracken will be [...]
Mereo BioPharma to Present at the Cowen and Company 39th Annual Healthcare Conference on Tuesday, March 12, 2019
05/03/2019
LONDON, March 05, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, is pleased to announce that Dr. Denise Scots-Knight, Chief [...]
Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics
05/03/2019
- Significant therapeutic benefit achieved whether or not patients had previously failed treatment with existing FDA-approved biological drug. - 61-63% of patients achieved a positive HiSCR (the accepted measure of [...]
Notice to convene Annual General Meeting
05/03/2019
Orphazyme A/S Company announcement No. 06/2019 Company Registration No. 32266355 Copenhagen, Denmark, March 5, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for [...]
Alder BioPharmaceuticals® to Present at the Cowen and Company 39th Annual Health Care Conference
05/03/2019
BOTHELL, Wash, March 05, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
05/03/2019
WALTHAM, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the following investor conferences during the month of March: Cowen and [...]
The Largest Study Conducted with Bionano’s Platform to Date Reveals Never-Before-Seen Human Genomic Structural Variations
05/03/2019
Bionano optical mapping uniquely identifies structural variation, a previously inaccessible class of genomic variation associated with disease phenotypes, in a study comprising 154 humans across 26 distinct populations [...]
CareDx Welcomes Initiatives from US Government to Support Transplant Care
05/03/2019
CMS initiative “Patients over Paperwork” aims to increase organ availability BRISBANE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, [...]
Minerva Neurosciences to Report Fiscal 2018 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2019
05/03/2019
Management to host conference call WALTHAM, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to [...]
Outlook Therapeutics Regains Compliance With All Nasdaq Listing Requirements
05/03/2019
CRANBURY, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) announced today that the Company received formal notice from The Nasdaq Stock Market LLC that the Company has [...]
Passage Bio to Present at the Cowen and Company 39th Annual Health Care Conference
05/03/2019
PHILADELPHIA, March 05, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases, today announced that [...]
UAHC Subsidiary American Sustainable Rubber Company, LLC Garners Coverage in International Business Times & This Giant Beast That is the Global Economy
05/03/2019
CHICAGO, March 05, 2019 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC: UAHC), an emerging technology holding company, today announced its wholly-owned subsidiary American Sustainable Rubber Company, [...]
Silicon Valley TMS Now Offering Cutting Edge Mental Health Technology for Obsessive-Compulsive Disorder (OCD) in Northern California
05/03/2019
Deep Transcranial Magnetic Stimulation (Deep TMS) therapy poised to make an impact for patients living with OCD as facility expands its treatment options SAN JOSE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Silicon [...]
Intra-Cellular Therapies to Present at The Cowen and Company 39th Annual Health Care Conference
05/03/2019
NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Daré Bioscience, Inc. to Present at the Cowen 39th Annual Healthcare Conference
05/03/2019
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the [...]
Kezar Life Sciences to Present at the Cowen and Company 39th Annual Health Care Conference
05/03/2019
SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Allena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference
05/03/2019
NEWTON, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Inhibikase Therapeutics Appoints Leading Experts in Parkinson’s Disease to its Scientific Advisory Board
05/03/2019
ATLANTA and BOSTON, March 05, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative [...]
Melinta Therapeutics to Report Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019
05/03/2019
MORRISTOWN, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]

Pages